According to L'Oréal, the company has acquired an additional 10% of Galderma Group AG from a consortium led by EQT, including Sunshine SwissCo GmbH, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd. The amount of the transaction was not disclosed, but it increases L'Oréal's stake in Galderma to 20%. This transaction will be finalized after customary regulatory approvals, expected in the first quarter of 2026.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Per the announcement, L'Oréal's new stake in Galderma will allow for the appointment of two non-independent directors representing L'Oréal on Galderma's board of directors. These appointments will replace members of the consortium led by EQT at the Annual General Meeting in 2026. The agreement includes standard clauses for this type of investment, and the existing shareholders' agreement with Sunshine SwissCo GmbH will terminate upon completion of the transaction.
The transaction, supported by Galderma, will be financed through L'Oréal's available equity and credit lines. L'Oréal states that this operation is part of its intention to strengthen the scientific partnership with Galderma. Nicolas Hieronimus, CEO of L'Oréal, emphasized the importance of aesthetics in connection with the company's core business, beauty. Once the transaction is finalized, L'Oréal will consolidate its stake by equity accounting of Galderma's results.
L'Oréal réalise un excellent début d'année avec une croissance à données comparables ajustée de + 6,7 %
La reprise amorcée au second semestre 2025 dans nos deux plus grands pays... s'est poursuivie.
Risks mentioned
Impact négatif de – 5,5 % des effets monétaires.
Perturbations géopolitiques et macroéconomiques actuelles.
Opportunities identified
Accélération des gains de parts de marché à travers le monde.
Leadership en E-commerce permettant des résultats spectaculaires.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
